Clinical Features of Patients with Stage IV Gastric Cancer.
10.5230/jkgca.2008.8.2.91
- Author:
Yoo Seok KIM
1
;
Sung Soo KIM
;
Young Don MIN
Author Information
1. Department of Surgery, College of Medicine, Chosun University, Gwangju, Korea. ydmin@chosun.ac.kr
- Publication Type:Original Article
- Keywords:
Stage IV;
Gastric cancer;
Gastrectomy;
Lymph node dissection;
Chemotherapy
- MeSH:
Endoscopy;
Female;
Gastrectomy;
Humans;
Laparotomy;
Lymph Node Excision;
Male;
Neoplasm Metastasis;
Prognosis;
Retrospective Studies;
Stomach Neoplasms;
Survival Rate
- From:Journal of the Korean Gastric Cancer Association
2008;8(2):91-96
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The early detection of gastric cancer and accuracy of preoperative staging has currently been on the increase due to the development of endoscopy and imaging techniques, but there are still many cases of advanced gastric cancer detected at the first diagnosis and there are also many cases of stage IV gastric cancer diagnosed after a postoperative pathological examination. Although the prognosis of stage IV gastric cancer is very poor, this study was performed to determine the value of the use of aggressive treatment determined after a clinical analysis. MATERIALS AND METHODS: We retrospectively analyzed 150 patients that were diagnosed with stage IV gastric cancer among 1376 patients who underwent a laparotomy for gastric cancer from January 1994 to December 2006. RESULTS: Of the 150 patients with stage IV gastric cancer who underwent a laparotomy, there were 104 men and 46 women. The mean patient age was 57.8 years (age range, 28~93 years). A subtotal gastrectomy or total gastrectomy was performed in 119 patients and 31 patients underwent an explorative laparotomy. The mean survival time of patients that underwent a gastrectomy and patients that did not undergo a gastrectomy was 722 days (range, 14~4,559 days) and 173 days (range, 16~374 days), respectively this result was statistically significant. When patients that underwent a gastrectomy were classified according to the TNM stage, the mean survival time of 33 patients with stage T4 disease was 534 days (range, 17~3,378 days) and the mean survival time of 63 patients with stage N3 disease was 521 days (range, 14~4,190 days), but there was no statistical significance. Chemotherapy was administered to 98 patients and 52 patients did not receive chemotherapy. The mean survival time of patients that received chemotherapy was 792 days (range, 36~4,559 days) and the mean survival time of patients that did not receive chemotherapy was 243 days (range, 14~2,413 days), with statistical significance. CONCLUSION: If there is no evidence of distant metastasis in stage IV gastric cancer, one can expect improvement of the survival rate by the use of aggressive treatment, including curative gastric resection with radical lymph node dissection and chemotherapy.
